Retracted Article: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway

Breast cancer is the most frequent malignancy diagnosed in women, and Gemcitabine-based therapy is frequently used to treat late-stage breast cancer. miR-199a-5p plays a tumor-suppressive role in breast cancer. This work aimed to explore the mechanism of miR-199a-5p plus Gemcitabine in breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Dingmei, Ye, Xian, Wang, Xiyue, He, Guangning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065560/
https://www.ncbi.nlm.nih.gov/pubmed/35514680
http://dx.doi.org/10.1039/c9ra00016j

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065560/
https://www.ncbi.nlm.nih.gov/pubmed/35514680
http://dx.doi.org/10.1039/c9ra00016j

Ejemplares similares